Recent Advances in the Application of Silver Nanoparticles for Enhancing Phototherapy Outcomes
Pharmaceuticals · 27.06.2025 · 18 (7) · 970
DOI: 10.3390/ph18070970 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 27.06.2025. Verfasst von Rebeca M Melo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Fundamental, Universidade Federal de Pernambuco, Recife 50670-901, Brazil. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação de Amparo à Ciência e Tecnologia de Pernambuco, Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
The therapeutic use of silver nanoparticles (AgNPs) has been increasing, especially in phototherapy strategies. The plasmonic properties of AgNPs have contributed to their excellent results as phototherapeutic agents, namely for photodynamic therapy (PDT), photothermal therapy (PTT), and photodynamic inactivation of microorganisms. Moreover, the capacity of these nanostructures to release silver ions (Ag+) and enhance the production of reactive oxygen species (ROS) has been explored in combination with light to treat several diseases. Moreover, synthesis, functionalization, and conjugation strategies with targeting agents have been widely studied to optimize selectivity and maximize the therapeutic efficacy of these nanoplatforms. In this work, we reviewed the recent advancements (2019–2024) in the use of AgNPs for phototherapy applications, with an emphasis on evaluating therapeutic efficacy and specific targeting. According to the literature, in oncology, AgNPs have been predominately employed in PTT-based strategies, demonstrating significant tumor cell death and preservation of healthy tissues, in both in vitro and in vivo studies. Concurrently, AgNP-mediated PDT has emerged as a promising approach for the eradication of bacteria and fungi, particularly those commonly associated with antibiotic resistance. The compiled data indicate that AgNPs represent an innovative and effective therapeutic alternative, with a strong potential for clinical translation, in both cancer treatment and the management of hard-to-treat infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Química Fundamental, Universidade Federal de Pernambuco, Recife 50670-901, Brazil.
- Departamento de Química & CESAM, Universidade de Aveiro, 3810-193 Aveiro, Portugal.
ORCID-Profile: Rebeca M Melo, Joalen P Monte, Goreti Pereira
Förderung
- National Council for Scientific and Technological Development
- Fundação de Amparo à Ciência e Tecnologia de Pernambuco
- Fundação para a Ciência e a Tecnologia
- FCT (Fundação para a Ciência e a Tecnologia I.P.)
- CNPq
- FACEPE
- CAPES
Zitieren
APA
Melo, R. M., Albuquerque, G. M., Monte, J. P., Pereira, G. A. L., & Pereira, G. (2025). Recent Advances in the Application of Silver Nanoparticles for Enhancing Phototherapy Outcomes. Pharmaceuticals, 18(7), 970. https://doi.org/10.3390/ph18070970
Vancouver
Melo RM, Albuquerque GM, Monte JP, Pereira GAL, Pereira G. Recent Advances in the Application of Silver Nanoparticles for Enhancing Phototherapy Outcomes. Pharmaceuticals. 2025;18(7):970. doi:10.3390/ph18070970
BibTeX
@article{Melo2025,
author = {Melo, Rebeca M and Albuquerque, Gabriela M and Monte, Joalen P and Pereira, Giovannia A L and Pereira, Goreti},
title = {Recent Advances in the Application of Silver Nanoparticles for Enhancing Phototherapy Outcomes},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {7},
pages = {970},
doi = {10.3390/ph18070970}
}
EUVIMED